Proprio’s flagship system, the Paradigm, has entered its first of several ORs around the United States in a non-clinical capacity to capture unique surgical data, which will be used to accelerate future development. The company is working with select hospital systems, under Institutional Review Board approval, in a phased approach to capture real-time data that will identify data-driven product solutions in the operating room.
Proprio is already at capacity for its initial research sites this year, and the company is prioritizing select accounts for its broader commercial release in 2024.
Proprio is capturing data in the OR – prior to using the Paradigm system for clinical use – and will activate its advanced navigation capabilities upon FDA clearance. By capturing both preoperative and intraoperative data, Proprio’s future applications will offer new, robust insight into surgical performance and device placement throughout the entire surgical journey.
Proprio applies volumetric intelligence™ technology via a multi-modal sensor array and advanced computer platform, which is engineered to enhance surgical performance by creating a real-time view of the anatomy without exposure to radiation. The system is intended to help surgeons “see” better, and is designed to be intuitive to use.
“Our goal at Proprio is to enhance what clinicians are able to do and help them to deliver the best medical care more efficiently and effectively. Our data-informed platform allows all members of the surgical team access to the right information, at the right time, in the right environment. By passively capturing data in the background of surgery, we understand and quantify surgery better and are positioned to create the most data-rich platform for surgeons,” said Gabriel Jones, CEO and co-founder of Proprio.
Proprio's flagship system, the Paradigm, has entered its first of several ORs around the United States in a non-clinical capacity to capture unique surgical data, which will be used to accelerate future development. The company is working with select hospital systems, under Institutional Review Board approval, in a phased approach to capture...
Proprio’s flagship system, the Paradigm, has entered its first of several ORs around the United States in a non-clinical capacity to capture unique surgical data, which will be used to accelerate future development. The company is working with select hospital systems, under Institutional Review Board approval, in a phased approach to capture real-time data that will identify data-driven product solutions in the operating room.
Proprio is already at capacity for its initial research sites this year, and the company is prioritizing select accounts for its broader commercial release in 2024.
Proprio is capturing data in the OR – prior to using the Paradigm system for clinical use – and will activate its advanced navigation capabilities upon FDA clearance. By capturing both preoperative and intraoperative data, Proprio’s future applications will offer new, robust insight into surgical performance and device placement throughout the entire surgical journey.
Proprio applies volumetric intelligence™ technology via a multi-modal sensor array and advanced computer platform, which is engineered to enhance surgical performance by creating a real-time view of the anatomy without exposure to radiation. The system is intended to help surgeons “see” better, and is designed to be intuitive to use.
“Our goal at Proprio is to enhance what clinicians are able to do and help them to deliver the best medical care more efficiently and effectively. Our data-informed platform allows all members of the surgical team access to the right information, at the right time, in the right environment. By passively capturing data in the background of surgery, we understand and quantify surgery better and are positioned to create the most data-rich platform for surgeons,” said Gabriel Jones, CEO and co-founder of Proprio.
Copy to clipboard 
